Laborie Announces First Procedures in ENDURE 1 Study with the Optilume® Ureteric Drug-Coated Balloon
Landmark procedures launch the ENDURE 1 clinical study evaluating Optilume's safety and feasibility as a new minimally invasive option for patients with benign ureteric strictures. PORTSMOUTH, N.H., ...
TUCSON, Ariz. (KVOA) — If you are a person that struggles with problems urinating then Carondelet St. Mary's may have an answer that doesn't require a surgical procedure. St. Mary's Hospital has ...
PORTSMOUTH, N.H., Jan. 17, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its ...
Dr. Austen Slade, in Boise, Idaho, is proud to announce that he is the first urologist in the state to introduce the Optilume® BPH Catheter System. The Optilume technology has been a game changer.
PORTSMOUTH, N.H., May 8, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic and therapeutic urology, announced the publication of three-year outcomes from ...
Plymouth-based medical technology company Urotronic is launching an early feasibility trial for a new drug-coated balloon treatment for narrowed urethras in men, a company announcement says. The trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results